Puissance Life Science Opportunities Fund VI
Related Filers (9)
- Bellerophon Therapeutics, Inc. (14)
- Wang Theodore T (8)
- Puissance Capital Management LP (8)
- Puissance Capital Fund (GP) LLC (8)
- Puissance Capital Management (GP) LLC (5)
- SCYNEXIS INC (3)
- Puissance Cross-Border Opportunities V LLC (2)
- Tracon Pharmaceuticals, Inc. (2)
- Puissance Cross-Border Opportunities IV LLC (2)
- Show More ...
Other (2)
144
Wednesday, 6/7/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 5/18/2023
Filing for proposed sale of securities under Rule 144
Ownership (17)
SC 13D/A
Wednesday, 10/18/2023
Bellerophon Therapeutics, Inc.: Major Shareholders
SC 13D/A
Tuesday, 10/17/2023
Bellerophon Therapeutics, Inc.: Major Shareholders
4
Monday, 10/16/2023
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 6/8/2023
Bellerophon Therapeutics, Inc.: Major Shareholders
4
Wednesday, 6/7/2023
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 5/22/2023
Bellerophon Therapeutics, Inc.: Major Shareholders
4
Friday, 5/19/2023
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/8/2021
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 4/28/2021
Bellerophon Therapeutics, Inc.: Major Shareholders
4
Monday, 4/26/2021
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/11/2021
SCYNEXIS INC: Major Shareholders
SC 13D
Friday, 5/22/2020
Bellerophon Therapeutics, Inc.: Major Shareholders
4
Friday, 5/22/2020
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
SCYNEXIS INC: Major Shareholders
SC 13G
Friday, 3/15/2019
SCYNEXIS INC: Major Shareholders
4
Monday, 12/3/2018
Tracon Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4/A
Monday, 12/3/2018
Tracon Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities